An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease

Overview of attention for article published in International Journal of Colorectal Disease, September 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 61 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 9,983 followers.

RT @SpringerSurgery: FREE to read in Int J Colorectal Disease: An updated systematic review and meta-analysis about the safety and efficacy…

31 Oct 2019

Reply Repost Favourite

FREE to read in Int J Colorectal Disease: An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease https://t.co/EqiYpHAkt5 #SharedIt #colorectalresearch http

31 Oct 2019

Reply Repost Favourite